Cargando…

Serum folate and FIGLU excretion in patients with trophoblastic tumours.

Detalles Bibliográficos
Autores principales:	Hughes, M., Bagshawe, K. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1968
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008223/ https://www.ncbi.nlm.nih.gov/pubmed/4296101

Ejemplares similares

Cellular Reaction in Trophoblastic Tumours
por: Elston, C. W., et al.
Publicado: (1973)

ORAL CONTRACEPTIVES AND POST-MOLAR TROPHOBLASTIC TUMOURS
por: Bagshawe, K.D., et al.
Publicado: (1980)

The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system.
por: Rushworth, A. G., et al.
Publicado: (1968)

International symposium on gestational trophoblastic tumours: 23, 24 May 1979, Charing Cross Hospital, London
por: Newlands, E. S., et al.
Publicado: (1980)

Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy.
por: Long, M. G., et al.
Publicado: (1992)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Trial of an aromatic retinoid in patients with solid tumours.
por: Rustin, G. J., et al.
Publicado: (1982)

Proceedings: The value of hormone measurements in tumour management.
por: Bagshawe, K. D.
Publicado: (1974)

Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours.
por: Coppack, S., et al.
Publicado: (1983)

Tumour growth and anti-mitotic action. The role of spontaneous cell losses.
por: Bagshawe, K. D.
Publicado: (1968)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?
por: Bagshawe, K. D.
Publicado: (1983)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

Serum folate levels and hypertension
por: Lee, Yoonkyung, et al.
Publicado: (2022)

The effect of neuraminidase on the immunogenicity of the Landschütz ascites tumour: site and mode of action.
por: Currie, G. A., et al.
Publicado: (1968)

The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.
por: Currie, G. A., et al.
Publicado: (1968)

Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
por: Currie, G. A., et al.
Publicado: (1969)

Folate catabolism in tumour-bearing rats and rats treated with methotrexate.
por: Saleh, A. M., et al.
Publicado: (1981)

Folate Assays: Serum or Red Cell?
por: Phekoo, Karen, et al.
Publicado: (1997)

Serum folate concentration and the incidence of lung cancer
por: Durda, Katarzyna, et al.
Publicado: (2017)

Tumour-marker levels and prognosis in malignant teratoma of the testis.
por: Germa-Lluch, J. R., et al.
Publicado: (1980)

Collaborative study of bronchial tumour-associated antigens.
por: Gennings, J. N., et al.
Publicado: (1981)

Serum Homocysteine and Folate Levels in Korean Schizophrenic Patients
por: Kim, Tae Ho, et al.
Publicado: (2011)

Dietary Intake of Folate and Assessment of the Folate Deficiency Prevalence in Slovenia Using Serum Biomarkers
por: Pravst, Igor, et al.
Publicado: (2021)

Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
por: Begent, R. H., et al.
Publicado: (1982)

Serum Folate and Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism Adjusted for Folate Intake
por: Nishio, Kazuko, et al.
Publicado: (2008)

Placental site trophoblastic tumour: a rare but potentially curable cancer
por: Gillespie, A M, et al.
Publicado: (2000)

Long-term effects of chemotherapy on lymphocyte chromosomes from patients treated for gestational trophoblastic tumours.
por: Reeves, B. R., et al.
Publicado: (1985)

Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies
por: Wang, Rong, et al.
Publicado: (2014)

Smoking status in relation to serum folate and dietary vitamin intake
por: Vardavas, Constantine I, et al.
Publicado: (2008)

Folate intake, serum folate levels and esophageal cancer risk: an overall and dose-response meta-analysis
por: Zhao, Yan, et al.
Publicado: (2017)

Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.
por: Ledermann, J. A., et al.
Publicado: (1988)

Mechanistic target of rapamycin (mTOR) regulates trophoblast folate uptake by modulating the cell surface expression of FR-α and the RFC
por: Rosario, Fredrick J., et al.
Publicado: (2016)

It is never too late to rethink serum folate()
por: Fertrin, Kleber Yotsumoto
Publicado: (2018)

Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
por: Kaye, S. B., et al.
Publicado: (1979)

Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion
por: Sandri, Silvana, et al.
Publicado: (2014)

Interaction of Serum microRNAs and Serum Folate With the Susceptibility to Pancreatic Cancer
por: Tian, Yao, et al.
Publicado: (2015)

Serum Folate deficiency in HCV related Hepatocellular Carcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2022)

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989)

Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)
por: Chan Wah Hak, Charleen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dj7q2ovc7likhu7c62riohphlm